Recent Publications
Transcriptomic Heterogeneity of Gleason Grade Group 5 Prostate Cancer.
Kishan AU, et al. Among authors: Liu Y, Schaeffer EM.
Eur Urol. 2020 May 24:S0302-2838(20)30349-3. doi: 10.1016/j.eururo.2020.05.009. Online ahead of print.
Staniorski CJ, Singal A, Nettey O, Yura E, Keeter MK, Kielb S, Hofer MD.
World J Urol. 2020 May 21. doi: 10.1007/s00345-020-03244-6. Online ahead of print.
Johnson EK, Jacobson DL, Finlayson C, Yerkes EB, Goetsch AL, Leeth EA, Cheng EY.
J Urol. 2020 May 20:101097JU000000000000081003. doi: 10.1097/JU.0000000000000810.03. Online ahead of print.
Kim S, Balmert L, Raval MV, Johnson EK, Abdullah F, Chu DI.
J Pediatr Surg. 2020 Apr 19:S0022-3468(20)30266-9. doi: 10.1016/j.jpedsurg.2020.04.006. Online ahead of print.
Patel MS, Halpern JA, Desai AS, Keeter MK, Bennett NE, Brannigan RE.
Urology. 2020 May;139:69-70. doi: 10.1016/j.urology.2019.11.066.
Darst BF, et al. Among authors: John EM, Murphy AB.
Eur Urol. 2020 May 11:S0302-2838(20)30328-6. doi: 10.1016/j.eururo.2020.04.060. Online ahead of print.
A novel immunocompetent model of metastatic prostate cancer-induced bone pain.
Liu Z, Murphy SF, Huang J, Zhao L, Hall CC, Schaeffer AJ, Schaeffer EM, Thumbikat P.
Prostate. 2020 May 14. doi: 10.1002/pros.23993. Online ahead of print.
Meyers TJ, et al. Among authors: Catalona WJ, Schaeffer EM, Abdulkadir SA, Kundu SD.
Int J Cancer. 2020 May 13. doi: 10.1002/ijc.33048. Online ahead of print.
Harris CJ, Corkum KS, Finlayson CA, Rowell EE, Laronda MM, Reimann MB, Yerkes EB, Cheng EY, Johnson EK.
J Urol. 2020 May 7:101097JU0000000000001128. doi: 10.1097/JU.0000000000001128. Online ahead of print.
NAD+ Controls Circadian Reprogramming through PER2 Nuclear Translocation to Counter Aging.
Levine DC, et al. Among authors: Lee C.
Mol Cell. 2020 Apr 24:S1097-2765(20)30236-7. doi: 10.1016/j.molcel.2020.04.010. Online ahead of print.